| Date | Time | Source | Headline | Symbol | Company |
| 09/13/2023 | 8:03AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NMRD | Nemaura Medical Inc |
| 09/13/2023 | 8:00AM | GlobeNewswire Inc. | Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program | NASDAQ:NMRD | Nemaura Medical Inc |
| 09/12/2023 | 9:26AM | GlobeNewswire Inc. | Nemaura Medical Announces Participation at HLTH 2023, Las Vegas | NASDAQ:NMRD | Nemaura Medical Inc |
| 09/11/2023 | 4:41PM | Edgar (US Regulatory) | Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8) | NASDAQ:NMRD | Nemaura Medical Inc |
| 09/11/2023 | 9:00AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NMRD | Nemaura Medical Inc |
| 09/08/2023 | 4:30PM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:NMRD | Nemaura Medical Inc |
| 09/08/2023 | 4:15PM | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:NMRD | Nemaura Medical Inc |
| 08/17/2023 | 8:30AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NMRD | Nemaura Medical Inc |
| 08/17/2023 | 8:30AM | GlobeNewswire Inc. | Nemaura Medical Announces SFDA Approval of sugarBEAT® | NASDAQ:NMRD | Nemaura Medical Inc |
| 08/14/2023 | 8:35AM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NMRD | Nemaura Medical Inc |
| 08/14/2023 | 8:30AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NMRD | Nemaura Medical Inc |
| 08/14/2023 | 8:30AM | GlobeNewswire Inc. | Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update | NASDAQ:NMRD | Nemaura Medical Inc |
| 08/11/2023 | 5:07PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NMRD | Nemaura Medical Inc |
| 08/11/2023 | 4:05PM | GlobeNewswire Inc. | Nemaura Medical Secures $6.5m in Non-Dilutive Funding | NASDAQ:NMRD | Nemaura Medical Inc |
| 08/10/2023 | 4:05PM | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:NMRD | Nemaura Medical Inc |
| 08/08/2023 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:NMRD | Nemaura Medical Inc |
| 08/03/2023 | 4:08PM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:NMRD | Nemaura Medical Inc |
| 07/17/2023 | 9:30AM | Edgar (US Regulatory) | Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] | NASDAQ:NMRD | Nemaura Medical Inc |
| 07/14/2023 | 9:25AM | GlobeNewswire Inc. | Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023 | NASDAQ:NMRD | Nemaura Medical Inc |
| 07/14/2023 | 9:18AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NMRD | Nemaura Medical Inc |
| 07/13/2023 | 4:31PM | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:NMRD | Nemaura Medical Inc |
| 06/29/2023 | 6:05AM | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | NASDAQ:NMRD | Nemaura Medical Inc |
| 06/27/2023 | 9:00AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:NMRD | Nemaura Medical Inc |
| 06/27/2023 | 9:00AM | GlobeNewswire Inc. | Nemaura Medical Scales-Up Pilot Expansion of proBEAT™; 56 Corporations in the U.S. Signed Up for Pilots in June 2023 | NASDAQ:NMRD | Nemaura Medical Inc |
| 06/22/2023 | 8:00AM | GlobeNewswire Inc. | Nemaura Medical to Participate at the Collision Conference in Toronto June 26-29, 2023 | NASDAQ:NMRD | Nemaura Medical Inc |
| 06/15/2023 | 8:00AM | GlobeNewswire Inc. | Nemaura Medical to Exhibit and Provide Live Product Demonstrations of Its Non-invasive Glucose Sensor at the 83rd Scientific Sessions of the American Diabetes Association June 23-26, 2023 | NASDAQ:NMRD | Nemaura Medical Inc |
| 05/15/2023 | 4:46PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) | NASDAQ:NMRD | Nemaura Medical Inc |
| 05/15/2023 | 6:28AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:NMRD | Nemaura Medical Inc |
| 04/07/2023 | 4:37PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:NMRD | Nemaura Medical Inc |
| 03/21/2023 | 8:00AM | GlobeNewswire Inc. | Nemaura Medical to Participate in Fireside Chat Hosted by EF Hutton | NASDAQ:NMRD | Nemaura Medical Inc |